Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes.
about
Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25CMolecular pathophysiology of myelodysplastic syndromes.CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.Differential expression of CDC25 phosphatases splice variants in human breast cancer cells.The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
P2860
Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@en
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@nl
type
label
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@en
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@nl
prefLabel
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@en
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@nl
P2860
P1433
P1476
Aberrant pre-mRNA splicing of ...... in myelodysplastic syndromes.
@en
P2093
Jonathan S Caudill
Julie C Porcher
P2860
P304
P356
10.1080/10428190801971690
P577
2008-05-01T00:00:00Z